• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331

Introduction to 3-Chloro-6-methyl-7-nitro (1H)Indazole (CAS No. 1000342-46-0)

3-Chloro-6-methyl-7-nitro (1H)Indazole, identified by the Chemical Abstracts Service Number (CAS No.) 1000342-46-0, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the indazole family, a class of nitrogen-containing heterocycles that are widely recognized for their diverse biological activities and potential therapeutic applications. The structural features of 3-Chloro-6-methyl-7-nitro (1H)Indazole, including the presence of a chloro substituent, a methyl group, and a nitro group, contribute to its unique chemical properties and reactivity, making it a valuable scaffold for drug discovery and development.

The indazole core is a fused bicyclic system consisting of a benzene ring and a pyrrole ring, both sharing two adjacent carbon atoms. This structural motif is prevalent in numerous bioactive natural products and synthetic compounds, underscoring its importance in medicinal chemistry. The introduction of electron-withdrawing and electron-donating groups at specific positions on the indazole ring can modulate its biological activity, making it an attractive platform for designing novel pharmacophores.

In recent years, 3-Chloro-6-methyl-7-nitro (1H)Indazole has been studied for its potential role in various biological processes. One of the most compelling areas of research involves its interaction with biological targets such as enzymes and receptors. The chloro substituent at the 3-position and the nitro group at the 7-position are particularly notable for their ability to influence the electronic properties of the molecule, thereby affecting its binding affinity and selectivity towards specific targets.

Recent studies have highlighted the compound's potential in modulating inflammatory pathways. In particular, 3-Chloro-6-methyl-7-nitro (1H)Indazole has been investigated for its ability to interact with transcription factors and signaling molecules involved in inflammation. The nitro group, known for its ability to undergo reduction to an amine, may play a crucial role in these interactions by altering the conformational flexibility of the molecule or by serving as a hydrogen bond acceptor.

Furthermore, the methyl group at the 6-position contributes to the steric environment of the indazole ring, which can be critical for optimizing binding interactions with biological targets. This structural feature allows for fine-tuning of pharmacokinetic properties such as solubility and metabolic stability, which are essential factors in drug development.

The synthesis of 3-Chloro-6-methyl-7-nitro (1H)Indazole involves multi-step organic transformations that highlight the synthetic versatility of indazole derivatives. Common synthetic routes include nucleophilic substitution reactions on pre-functionalized indazole precursors, followed by nitration and chlorination steps to introduce the desired substituents. These synthetic strategies leverage well-established chemical methodologies while also exploring novel approaches to improve yield and purity.

The pharmacological profile of 3-Chloro-6-methyl-7-nitro (1H)Indazole has been explored in both in vitro and in vivo models. Initial studies have demonstrated its potential as an inhibitor of certain enzymes implicated in diseases such as cancer and neurodegeneration. The ability of this compound to modulate enzyme activity suggests its utility as a lead compound for further derivatization to enhance potency and selectivity.

One particularly intriguing aspect of 3-Chloro-6-methyl-7-nitro (1H)Indazole is its potential role in anticancer therapy. Research indicates that it may interfere with key cellular pathways involved in tumor growth and progression. By targeting specific enzymes or receptors overexpressed in cancer cells, this compound could offer a novel mechanism of action compared to existing therapies. Additionally, its ability to induce apoptosis or inhibit proliferation in cancer cell lines makes it an attractive candidate for further investigation.

The compound's interaction with biological targets is further enhanced by its ability to undergo redox transformations. The nitro group can be reduced to an amine under specific conditions, which can alter its binding properties and potentially expose new pharmacological activities. This redox responsiveness makes 3-Chloro-6-methyl-7-nitro (1H)Indazole a versatile scaffold for designing prodrugs or bimodal therapeutic agents that can switch between different active forms depending on physiological conditions.

In conclusion, 3-Chloro-6-methyl-7-nitro (1H)Indazole (CAS No. 1000342-46-0) represents a promising compound in pharmaceutical research due to its unique structural features and diverse biological activities. Its potential applications in modulating inflammatory pathways, interacting with transcription factors, and serving as an anticancer agent make it a valuable scaffold for drug discovery efforts. Continued research into this compound will likely uncover additional therapeutic opportunities and refine our understanding of its mechanisms of action.

• 31208-76-1(1H-Indazole,5,7-dinitro-)
• 2942-42-9(7-Nitroindazole)
• 5401-94-5(5-nitro-1H-indazole)
• 7471-63-8(7-Methyl-8-nitroquinoline)
• 40621-84-9(3-Methyl-5-nitro-1H-indazole)
• 6494-19-5(3-Methyl-6-nitro-1H-indazole)
• 7597-18-4(6-nitro-1H-indazole)
• 13436-58-3(2-Methyl-7-nitro-2H-indazole)
• 221681-91-0(6-Methyl-1H-indazol-7-amine)
• 647853-25-6(1H-Indazol-7-amine, 3-methyl-5-nitro-)